The stock has witnessed a consistent decline since testing its record high in July 2021. Since then, the stock has plunged around 76% on the back of declining profits.

Know your stock | Is there a glimmer of hope for SeQuent Scientific?

Sequent Scientific Ltd, Hindustan Construction Company Ltd, Lloyds Metals & Energy Ltd and Mahindra CIE Automotive Ltd are among the other losers in the BSE’s ‘A’ group today, 13 March 2023.

GRM Overseas Ltd leads losers in ‘A’ group

In the smallcap segment, 36 stocks gave double-digit weekly returns. These include popular names such as Olectra Greentech, Kirloskar Oil Engines, Mangalore Chemicals, SeQuent Scientific, Jindal Saw, Usha Martin, Titagarh Wagons, Dishman Carbogen, Jindal Stainless, and South Indian Bank.

Sensex frowned upon bear party, but 36 smallcaps went on joyride last week

Mangalore Refinery And Petrochemicals Ltd, KSB Ltd, Swan Energy Ltd and Adani Green Energy Ltd are among the other gainers in the BSE’s ‘A’ group today, 10 March 2023.

Sequent Scientific Ltd leads gainers in ‘A’ group

Sequent Scientific share price: The counter’s 14-day relative strength index (RSI) came at 54.39. A level below 30 is defined as oversold while a value above 70 is considered overbought. The company’s stock has a negative price-to-equity (P/E) ratio of 703.10.

Sequent Scientific shares jump 15% after terminating Tineta Pharma’s proposed acquisition

Case Study: Sequent Scientific on how Terminating Acquisition can be Helpful

Sequent stock soars 13% on ending bid for Tineta Pharma

Sequent Scientific calls off acquisition of Tineta Pharma

Shilpa Medicare Ltd, Privi Speciality Chemicals Ltd, Maharashtra Seamless Ltd and Usha Martin Ltd are among the other gainers in the BSE’s ‘A’ group today, 09 March 2023.

In November 2022, SeQuent had announced the acquisition of Tineta Pharma for Rs 218 crore but the said transaction has not materialised

SeQuent Scientific rallies 15% on terminating pact to acquire Tineta Pharma

The stock has corrected over 79.4 percent from its lifetime highs tested in July 2021.

SeQuent Scientific zooms 14% on terminating Tineta Pharma acquisition

Sequent Scientific jumped 13.23% to Rs 70.63 after the company said that it will not acquire Tineta Pharma and the share purchase agreement entered by the company with Tineta and its promoters stands terminated.

Sequent Scientific gains on terminating pact to acquire Tineta

Hasn't faired well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

The stock has a moderate number of red flags

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

SeQuent Scientific Limited is a holding company that operates in pharmaceutical sector.

SeQuent Scientific Ltd